References
Key articles
American Diabetes Association. Standards of care in diabetes - 2025. Diabetes care. 2025 Jan;48(suppl 1):S1-352.Full text
Shah AS, Barrientos-Pérez M, Chang N, et al. ISPAD clinical practice consensus guidelines 2024: type 2 diabetes in children and adolescents. Horm Res Paediatr. 2024;97(6):555-83.Full text Abstract
Glaser N, Fritsch M, Priyambada L, et al. ISPAD clinical practice consensus guidelines 2022: diabetic ketoacidosis and hyperglycemic hyperosmolar state. Pediatr Diabetes. 2022 Nov;23(7):835-56. Abstract
Reference articles
1. American Diabetes Association. Standards of care in diabetes - 2025. Diabetes care. 2025 Jan;48(suppl 1):S1-352.Full text
2. Shah AS, Barrientos-Pérez M, Chang N, et al. ISPAD clinical practice consensus guidelines 2024: type 2 diabetes in children and adolescents. Horm Res Paediatr. 2024;97(6):555-83.Full text Abstract
3. Bhupathiraju SN, Hu FB. Epidemiology of obesity and diabetes and their cardiovascular complications. Circ Res. 2016 May 27;118(11):1723-35.Full text Abstract
4. Glaser N, Fritsch M, Priyambada L, et al. ISPAD clinical practice consensus guidelines 2022: diabetic ketoacidosis and hyperglycemic hyperosmolar state. Pediatr Diabetes. 2022 Nov;23(7):835-56. Abstract
5. Kaufman FR, Shaw J. Type 2 diabetes in youth: rates, antecedents, treatment, problems and prevention. Pediatr Diabetes. 2007 Dec;8(suppl 9):4-6. Abstract
6. Diabetes Australia Guideline Development Consortium. National evidence based guideline for case detection and diagnosis of type 2 diabetes. Jun 2009 [internet publication].Full text
7. Centers for Disease Control and Prevention. National diabetes statistics report: diabetes. May 2024 [internet publication].Full text
8. Misra S, Ke C, Srinivasan S, et al. Current insights and emerging trends in early-onset type 2 diabetes. Lancet Diabetes Endocrinol. 2023 Oct;11(10):768-82. Abstract
9. Xie J, Wang M, Long Z, et al. Global burden of type 2 diabetes in adolescents and young adults, 1990-2019: systematic analysis of the Global Burden of Disease Study 2019. BMJ. 2022 Dec 7;379:e072385.Full text Abstract
10. Centers for Disease Control and Prevention. National diabetes statistics report: diabetes. May 2024 [internet publication].Full text
11. NHS England. Children and young people diabetes toolkit. Jul 2024 [internet publication].Full text
12. Savage PJ, Bennett PH, Senter RG, et al. High prevalence of diabetes in young Pima Indians. Diabetes. 1979 Oct;28(10):937-42. Abstract
13. Lascar N, Brown J, Pattison H, et al. Type 2 diabetes in adolescents and young adults. Lancet Diabetes Endocrinol. 2017 Aug 25;6(1):69-80.Full text Abstract
14. Acton KJ, Burrows NR, Moore K, et al. Trends in diabetes prevalence among American Indian and Alaska native children, adolescents, and young adults. Am J Public Health. 2002 Sep;92(9):1485-90.Full text Abstract
15. Gahagan S, Silverstein J. Prevention and treatment of type 2 diabetes mellitus in children, with special emphasis on American Indian and Alaska Native children. American Academy of Pediatrics Committee on Native American Child Health. Pediatrics. 2003 Oct;112(4):e328.Full text Abstract
16. Lawrence JM, Divers J, Isom S, et al. Trends in prevalence of type 1 and type 2 diabetes in children and adolescents in the US, 2001-2017. JAMA. 2021 Aug 24;326(8):717-27.Full text Abstract
17. Perng W, Conway R, Mayer-Davis E, et al. Youth-onset type 2 diabetes: the epidemiology of an awakening epidemic. Diabetes Care. 2023 Mar 1;46(3):490-9.Full text Abstract
18. Arslanian S, Bacha F, Grey M, et al. Evaluation and Management of Youth-Onset Type 2 Diabetes: A Position Statement by the American Diabetes Association. Diabetes Care. 2018 Dec;41(12):2648-2668.Full text Abstract
19. Ogden CL, Carroll MD, Flegal KM. High body mass index for age among US children and adolescents, 2003-2006. JAMA. 2008 May 28;299(20):2401-5.Full text Abstract
20. Pinhas-Hamiel O, Zeitler P. The global spread of type 2 diabetes mellitus in children and adolescents. J Pediatr. 2005 May;146(5):693-700. Abstract
21. Strauss RS, Pollack HA. Epidemic increase in childhood overweight, 1986-1998. JAMA. 2001 Dec 12;286(22):2845-8.Full text Abstract
22. Haines L, Wan KC, Lynn R, et al. Rising incidence of type 2 diabetes in children in the U.K. Diabetes Care. 2007 May;30(5):1097-101.Full text Abstract
23. Miller J, Rosenbloom A, Silverstein J. Childhood obesity. J Clin Endocrinol Metab. 2004 Sep;89(9):4211-8.Full text Abstract
24. Nolan CJ, Damm P, Prentki M. Type 2 diabetes across generations: from pathophysiology to prevention and management. Lancet. 2011 Jul 9;378(9786):169-81. Abstract
25. Ornoy A. Prenatal origin of obesity and its complication: gestational diabetes, maternal overweight and the paradoxical effects of fetal growth restriction and macrosomia. Reprod Toxicol. 2011 Sep;32(2):205-12. Abstract
26. Diabetes UK. Type 2 diabetes in children and young people. Aug 2024 [internet publication].Full text
27. Cioana M, Deng J, Nadarajah A, et al. The prevalence of obesity among children with type 2 diabetes: a systematic review and meta-analysis. JAMA Netw Open. 2022 Dec 1;5(12):e2247186.Full text Abstract
28. Hsueh WA, Quiñones MJ. Role of endothelial dysfunction in insulin resistance. Am J Cardiol. 2003 Aug 18;92(4a):10J-7J. Abstract
29. Foster GD, Linder B, Baranowski T, et al; HEALTHY Study Group. A school-based intervention for diabetes risk reduction. N Engl J Med. 2010 Jul 29;363(5):443-53.Full text Abstract
30. Dabelea D, Hanson RL, Lindsay RS, et al. Intrauterine exposure to diabetes conveys risks for type 2 diabetes and obesity: a study of discordant sibships. Diabetes. 2000 Dec;49(12):2208-11.Full text Abstract
31. Ibáñez L, Suárez L, Lopez-Bermejo A, et al. Early development of visceral fat excess after spontaneous catch-up growth in children with low birth weight. J Clin Endocrinol Metab. 2008 Mar;93(3):925-8. Abstract
32. Ibáñez L, Ong K, Dunger DB, et al. Early development of adiposity and insulin resistance after catch-up weight gain in small-for-gestational-age children. J Clin Endocrinol Metab. 2006 Jun;91(6):2153-8. Abstract
33. Mericq V, Ong KK, Bazaes R, et al. Longitudinal changes in insulin sensitivity and secretion from birth to age three years in small- and appropriate-for-gestational-age children. Diabetologia. 2005 Dec;48(12):2609-14. Abstract
34. Mayer-Davis EJ, Dabelea D, Lamichhane AP, et al. Breast-feeding and type 2 diabetes in the youth of three ethnic groups: the SEARCH for diabetes in youth case-control study. Diabetes Care. 2008 Mar;31(3):470-5.Full text Abstract
35. Koletzko B. Long-term consequences of early feeding on later obesity risk. Nestle Nutr Workshop Ser Pediatr Program. 2006;58:1-18. Abstract
36. Arslanian S, Bacha F, Grey M, et al. Evaluation and management of youth-onset type 2 diabetes: a position statement by the American Diabetes Association. Diabetes Care. 2018 Dec;41(12):2648-68.Full text
37. Valaiyapathi B, Gower B, Ashraf AP. Pathophysiology of type 2 diabetes in children and adolescents. Curr Diabetes Rev. 2020;16(3):220-9.Full text Abstract
38. Kelsey MM, Zeitler PS. Insulin resistance of puberty. Curr Diab Rep. 2016 Jul;16(7):64. Abstract
39. Arslanian SA. Metabolic differences between Caucasian and African-American children and the relationship to type 2 diabetes mellitus. J Pediatr Endocrinol Metab. 2002 Apr;15 Suppl 1:509-17. Abstract
40. Hanis CL, Boerwinkle E, Chakraborty R. A genome-wide search for human non-insulin-dependent (type 2) diabetes genes reveals a major susceptibility locus on chromosome 2. Nat Genet. 1996 Jun;13(2):161-6. Abstract
41. Copeland KC, Zeitler P, Geffner M, et al. Characteristics of adolescents and youth with recent-onset type 2 diabetes: the TODAY cohort at baseline. J Clin Endocrinol Metab. 2011 Jan;96(1):159-67.Full text Abstract
42. Srinivasan S, Chen L, Todd J, et al. The first genome-wide association study for type 2 diabetes in youth: the progress in diabetes genetics in youth (ProDiGY) Consortium. Diabetes. 2021 Apr;70(4):996-1005.Full text Abstract
43. Ahmed B, Sultana R, Greene MW. Adipose tissue and insulin resistance in obese. Biomed Pharmacother. 2021 May;137:111315.Full text Abstract
44. Lee S, Bacha F, Gungor N, et al. Comparison of different definitions of pediatric metabolic syndrome: relation to abdominal adiposity, insulin resistance, adiponectin, and inflammatory biomarkers. J Pediatr. 2008 Feb;152(2):177-84. Abstract
45. Hamdy O, Porramatikul S, Al-Ozairi E. Metabolic obesity: the paradox between visceral and subcutaneous fat. Curr Diabetes Rev. 2006 Nov;2(4):367-73. Abstract
46. Straczkowski M, Kowalska I. The role of skeletal muscle sphingolipids in the development of insulin resistance. Rev Diabet Stud. 2008 Spring;5(1):13-24.Full text Abstract
47. Yamamoto JM, Prado-Núñez S, Guarnizo-Poma M, et al. Association between serum transaminase levels and insulin resistance in euthyroid and non-diabetic adults. Diabetes Metab Syndr. 2020 Jan-Feb;14(1):17-21. Abstract
48. Tanase DM, Gosav EM, Costea CF, et al. The intricate relationship between type 2 diabetes mellitus (T2DM), insulin resistance (IR), and nonalcoholic fatty liver disease (NAFLD). J Diabetes Res. 2020;2020:3920196.Full text Abstract
49. Ndumele CE, Rangaswami J, Chow SL, et al. Cardiovascular-kidney-metabolic health: a presidential advisory from the American Heart Association. Circulation. 2023 Nov 14;148(20):1606-35.Full text Abstract
50. Zheng M, Lamb KE, Grimes C, et al. Rapid weight gain during infancy and subsequent adiposity: a systematic review and meta-analysis of evidence. Obes Rev. 2018 Mar;19(3):321-32.Full text Abstract
51. Arnesen EK, Thorisdottir B, Lamberg-Allardt C, et al. Protein intake in children and growth and risk of overweight or obesity: a systematic review and meta-analysis. Food Nutr Res. 2022;66.Full text Abstract
52. Cioana M, Deng J, Nadarajah A, et al. Prevalence of polycystic ovary syndrome in patients with pediatric type 2 diabetes: a systematic review and meta-analysis. JAMA Netw Open. 2022 Feb 1;5(2):e2147454.Full text Abstract
53. Kings College London. Onset and care of type 2 diabetes mellitus in people with a learning disability. 2022 [internet publication].Full text
54. Taggart L, Coates V, Truesdale-Kennedy M. Management and quality indicators of diabetes mellitus in people with intellectual disabilities. J Intellect Disabil Res. 2013 Dec;57(12):1152-63. Abstract
55. NHS England. National diabetes audit 2021-22, report 1: care processes and treatment targets, detailed analysis report. Oct 2023 [internet publication].Full text
56. Ogata BN, Hayes D. Position of the Academy of Nutrition and Dietetics: nutrition guidance for healthy children ages 2 to 11 years. J Acad Nutr Diet. 2014 Aug;114(8):1257-76. Abstract
57. Maessen SE, Nichols M, Cutfield W, et al. High but decreasing prevalence of overweight in preschool children: encouragement for further action. BMJ. 2023 Oct 9;383:e075736.Full text Abstract
58. Mead E, Brown T, Rees K, et al. Diet, physical activity and behavioural interventions for the treatment of overweight or obese children from the age of 6 to 11 years. Cochrane Database Syst Rev. 2017 Jun 22;(6):CD012651.Full text Abstract
59. World Health Organization. Carbohydrate intake for adults and children: WHO guideline Jul 2023 [internet publication].Full text
60. Belsky N, Tamaroff J, Shoemaker AH. Risk factors for progression to type 2 diabetes in a pediatric prediabetes clinic population. J Endocr Soc. 2023 Oct 9;7(11):bvad118.Full text Abstract
61. Kleber M, deSousa G, Papcke S, et al. Impaired glucose tolerance in obese white children and adolescents: three to five year follow-up in untreated patients. Exp Clin Endocrinol Diabetes. 2011 Mar;119(3):172-6. Abstract
62. Weiss R, Taksali SE, Tamborlane WV, et al. Predictors of changes in glucose tolerance status in obese youth. Diabetes Care. 2005 Apr;28(4):902-9.Full text Abstract
63. RISE Consortium. Impact of insulin and metformin versus metformin alone on β-cell function in youth with impaired glucose tolerance or recently diagnosed type 2 diabetes. Diabetes Care. 2018 Aug;41(8):1717-25.Full text Abstract
64. Khokhar A, Umpaichitra V, Chin VL, et al. Metformin use in children and adolescents with prediabetes. Pediatr Clin North Am. 2017 Dec;64(6):1341-53. Abstract
65. Serbis A, Giapros V, Kotanidou EP, et al. Diagnosis, treatment and prevention of type 2 diabetes mellitus in children and adolescents. World J Diabetes. 2021 Apr 15;12(4):344-65.Full text Abstract
66. Brickman WJ, Huang J, Silverman BL, et al. Acanthosis nigricans identifies youth at high risk for metabolic abnormalities. J Pediatr. 2010 Jan;156(1):87-92. Abstract
67. Jones AG, Hattersley AT. The clinical utility of C-peptide measurement in the care of patients with diabetes. Diabet Med. 2013 Jul;30(7):803-17.Full text Abstract
68. Leighton E, Sainsbury CA, Jones GC. A practical review of C-peptide testing in diabetes. Diabetes Ther. 2017 Jun;8(3):475-87.Full text Abstract
69. Chiang JL, Maahs DM, Garvey KC, et al. Type 1 diabetes in children and adolescents: a position statement by the American Diabetes Association. Diabetes Care. 2018 Sep;41(9):2026-44.Full text Abstract
70. Pihoker C, Gilliam LK, Ellard S, et al. Prevalence, characteristics and clinical diagnosis of maturity onset diabetes of the young due to mutations in HNF1A, HNF4A, and glucokinase: results from the SEARCH for Diabetes in Youth. J Clin Endocrinol Metab. 2013 Oct;98(10):4055-62.Full text Abstract
71. Peixoto-Barbosa R, Reis AF, Giuffrida FMA. Update on clinical screening of maturity-onset diabetes of the young (MODY). Diabetol Metab Syndr. 2020;12:50.Full text Abstract
72. Sanyoura M, Philipson LH, Naylor R. Monogenic diabetes in children and adolescents: recognition and treatment options. Curr Diab Rep. 2018 Jun 22;18(8):58. Abstract
73. Greeley SA, Naylor RN, Philipson LH, et al. Neonatal diabetes: an expanding list of genes allows for improved diagnosis and treatment. Curr Diab Rep. 2011 Dec;11(6):519-32.Full text Abstract
74. Hampl SE, Hassink SG, Skinner AC, et al. Clinical practice guideline for the evaluation and treatment of children and adolescents with obesity. Pediatrics. 2023 Feb 1;151(2):e2022060640.Full text Abstract
75. US Preventive Services Task Force, Mangione CM, Barry MJ, et al. Screening for prediabetes and type 2 diabetes in children and adolescents: US preventive services task force recommendation statement. JAMA. 2022 Sep 13;328(10):963-7.Full text Abstract
76. Viner R, White B, Christie D. Type 2 diabetes in adolescents: a severe phenotype posing major clinical challenges and public health burden. Lancet. 2017 Jun 3;389(10085):2252-60. Abstract
77. Simmons D, Voyle J, Rush E, et al. The New Zealand experience in peer support interventions among people with diabetes. Fam Pract. 2010 Jun;27(suppl 1):i53-61.Full text Abstract
78. Neyman A, Hannon TS, Committee on Nutrition. Low-carbohydrate diets in children and adolescents with or at risk for diabetes. Pediatrics. 2023 Oct 1;152(4):e2023063755.Full text Abstract
79. Willi SM, Martin K, Datko FM, et al. Treatment of type 2 diabetes in childhood using a very-low-calorie diet. Diabetes Care. 2004 Feb;27(2):348-53.Full text Abstract
80. Dela F, von Linstow ME, Mikines KJ, et al. Physical training may enhance beta-cell function in type 2 diabetes. Am J Physiol Endocrinol Metab. 2004 Nov;287(5):E1024-31.Full text Abstract
81. Marwick TH, Hordern MD, Miller T, et al. Exercise training for type 2 diabetes mellitus: impact on cardiovascular risk: a scientific statement from the American Heart Association. Circulation. 2009 Jun 30;119(25):3244-62.Full text Abstract
82. McCall A, Raj R. Exercise for prevention of obesity and diabetes in children and adolescents. Clin Sports Med. 2009 Jul;28(3):393-421. Abstract
83. Christie D, Strange V, Allen E, et al. Maximising engagement, motivation and long term change in a structured intensive education programme in diabetes for children, young people and their families: Child and Adolescent Structured Competencies Approach to Diabetes Education (CASCADE). BMC Pediatr. 2009 Sep 15;9:57.Full text Abstract
84. Misra A, Nigam P, Hills AP, et al. Consensus physical activity guidelines for Asian Indians. Diabetes Technol Ther. 2012 Jan;14(1):83-98. Abstract
85. Johnson ST, Newton AS, Chopra M, et al. In search of quality evidence for lifestyle management and glycemic control in children and adolescents with type 2 diabetes: a systematic review. BMC Pediatr. 2010 Dec 23;10:97.Full text Abstract
86. TODAY Study Group; Zeitler P, Hirst K, Pyle L, et al. A clinical trial to maintain glycemic control in youth with type 2 diabetes. N Engl J Med. 2012 Jun 12;366(24):2247-56.Full text Abstract
87. Nathan DM, Buse JB, Davidson MB, et al. Medical management of hyperglycaemia in type 2 diabetes mellitus: a consensus algorithm for the initiation and adjustment of therapy. A consensus statement from the American Diabetes Association and the European Association for the Study of Diabetes. Diabetes Care. 2009 Jan;32(1):193-203.Full text Abstract
88. Tamborlane WV, Barrientos-Pérez M, Fainberg U, et al. Liraglutide in children and adolescents with type 2 diabetes. N Engl J Med. 2019 Aug 15;381(7):637-46.Full text Abstract
89. Tamborlane WV, Bishai R, Geller D, et al. Once-weekly exenatide in youth with type 2 diabetes. Diabetes Care. 2022 Aug 1;45(8):1833-40.Full text Abstract
90. Arslanian SA, Hannon T, Zeitler P, et al. Once-weekly dulaglutide for the treatment of youths with type 2 diabetes. N Engl J Med. 2022 Aug 4;387(5):433-43.Full text Abstract
91. Laffel LM, Danne T, Klingensmith GJ, et al. Efficacy and safety of the SGLT2 inhibitor empagliflozin versus placebo and the DPP-4 inhibitor linagliptin versus placebo in young people with type 2 diabetes (DINAMO): a multicentre, randomised, double-blind, parallel group, phase 3 trial. Lancet Diabetes Endocrinol. 2023 Mar;11(3):169-81.Full text Abstract
92. Tamborlane WV, Laffel LM, Shehadeh N, et al. Efficacy and safety of dapagliflozin in children and young adults with type 2 diabetes: a prospective, multicentre, randomised, parallel group, phase 3 study. Lancet Diabetes Endocrinol. 2022 May;10(5):341-50.Full text Abstract
93. Shehadeh N, Barrett T, Galassetti P, et al. Dapagliflozin or saxagliptin in pediatric type 2 diabetes. NEJM Evid. 2023 Dec;2(12):EVIDoa2300210.Full text Abstract
94. McCall AL, Lieb DC, Gianchandani R, et al. Management of individuals with diabetes at high risk for hypoglycemia: an endocrine society clinical practice guideline. J Clin Endocrinol Metab. 2023 Feb 15;108(3):529-62.Full text Abstract
95. National Institute for Health and Care Excellence. Continuous subcutaneous insulin infusion for the treatment of diabetes. July 2008 [internet publication].Full text
96. Medicines and Healthcare Products Regulatory Agency. GLP-1 receptor agonists: reports of diabetic ketoacidosis when concomitant insulin was rapidly reduced or discontinued Jun 2019 [internet publication].Full text
97. World Gastroenterology Organisation and International Federation for the Surgery of Obesity and Metabolic Diseases. Obesity. 2023 [internet publication].Full text
98. Poliakin L, Roberts A, Thompson KJ, et al. Outcomes of adolescents compared with young adults after bariatric surgery: an analysis of 227,671 patients using the MBSAQIP data registry. Surg Obes Relat Dis. 2020 Oct;16(10):1463-73. Abstract
99. Riddle MC, Cefalu WT, Evans PH, et al. Consensus report: definition and interpretation of remission in type 2 diabetes. Diabetes Care. 2021 Aug 30;44(10):2438-44.Full text Abstract
100. Inge TH, Courcoulas AP, Jenkins TM, et al. Weight loss and health status 3 Years after bariatric surgery in adolescents. N Engl J Med. 2016 Jan 14;374(2):113-23.Full text Abstract
101. Inge TH, Miyano G, Bean J, et al. Reversal of type 2 diabetes mellitus and improvements in cardiovascular risk factors after surgical weight loss in adolescents. Pediatrics. 2009 Jan;123(1):214-22. Abstract
102. National Institute of Health Care and Excellence. Diabetes (type 1 and type 2) in children and young people: diagnosis and management. May 2023 [internet publication].Full text
103. Shankar RR, Zeitler P, Deeb A, et al. A randomized clinical trial of the efficacy and safety of sitagliptin as initial oral therapy in youth with type 2 diabetes. Pediatr Diabetes. 2022 Mar;23(2):173-82. Abstract
104. Jalaludin MY, Deeb A, Zeitler P, et al. Efficacy and safety of the addition of sitagliptin to treatment of youth with type 2 diabetes and inadequate glycemic control on metformin without or with insulin. Pediatr Diabetes. 2022 Mar;23(2):183-93. Abstract
105. ClinicalTrials.gov. Phase 3 alogliptin pediatric study. ClinicalTrials.gov Identifier: NCT02856113. Oct 2022 [internet publication].Full text
106. Adeyemi A, Rascati K, Strassels S. The need for oral antidiabetic treatment adherence studies in the pediatric population. Clin Ther. 2010 Jul;32(7):1306-7. Abstract
107. Kawahara R, Amemiya T, Yoshino M, et al. Dropout of young non-insulin-dependent diabetics from diabetic care. Diabetes Res Clin Pract. 1994 Jul;24(3):181-5. Abstract
108. TODAY Study Group, TODAY Study Group. Long-term outcomes among young adults with type 2 diabetes based on durability of glycemic control: results from the TODAY Cohort Study. Diabetes Care. 2022 Nov 1;45(11):2689-97.Full text Abstract
109. Rosenbloom AL. Hyperglycemic hyperosmolar state: an emerging pediatric problem. J Pediatr. 2010 Feb;156(2):180-4. Abstract
110. Abraham MB, Karges B, Dovc K, et al. ISPAD clinical practice consensus guidelines 2022: assessment and management of hypoglycemia in children and adolescents with diabetes. Pediatr Diabetes. 2022 Dec;23(8):1322-40.Full text
111. Marx N, Federici M, Schütt K, et al. 2023 ESC guidelines for the management of cardiovascular disease in patients with diabetes. Eur Heart J. 2023 Oct 14;44(39):4043-140.Full text
112. TODAY Study Group. Rapid rise in hypertension and nephropathy in youth with type 2 diabetes: the TODAY clinical trial. Diabetes Care. 2013 Jun;36(6):1735-41.Full text Abstract
113. TODAY Study Group. Lipid and inflammatory cardiovascular risk worsens over 3 years in youth with type 2 diabetes: the TODAY clinical trial. Diabetes Care. 2013 Jun;36(6):1758-64.Full text Abstract
114. Bjornstad P, Drews KL, et al; TODAY Study Group. Long-term complications in youth-onset type 2 diabetes. N Engl J Med. 2021 Jul 29;385(5):416-26.Full text Abstract
115. Svensson M, Sundkvist G, Arnqvist HJ, et al. Signs of nephropathy may occur early in young adults with diabetes despite modern diabetes management: results from the nationwide population-based Diabetes Incidence Study in Sweden (DISS). Diabetes Care. 2003 Oct;26(10):2903-9.Full text Abstract
116. Maahs DM, Snively BM, Bell RA, et al. Higher prevalence of elevated albumin excretion in youth with type 2 than type 1 diabetes: the SEARCH for Diabetes in Youth study. Diabetes Care. 2007 Oct;30(10):2593-8.Full text Abstract
117. Sanz M, Ceriello A, Buysschaert M, et al. Scientific evidence on the links between periodontal diseases and diabetes: consensus report and guidelines of the joint workshop on periodontal diseases and diabetes by the International Diabetes Federation and the European Federation of Periodontology. Diabetes Res Clin Pract. 2018 Mar;137:231-41. Abstract
118. Khader YS, Dauod AS, El-Qaderi SS, et al. Periodontal status of diabetics compared with nondiabetics: a meta-analysis. J Diabetes Complications. 2006 Jan-Feb;20(1):59-68. Abstract
119. Shaw JE, Punjabi NM, Wilding JP, et al. Sleep-disordered breathing and type 2 diabetes: a report from the International Diabetes Federation Taskforce on Epidemiology and Prevention. Diabetes Res Clin Pract. 2008 Jul;81(1):2-12. Abstract
120. Ke C, Lau E, Shah BR, et al. Excess burden of mental illness and hospitalization in young-onset type 2 diabetes: a population-based cohort study. Ann Intern Med. 2019 Feb 5;170(3):145-54. Abstract
121. Betts P, Brink SJ, Swift PG, et al. Management of children with diabetes requiring surgery. Pediatr Diabetes. 2007 Aug;8(4):242-7. Abstract
Use of this content is subject to our disclaimer